Propiedad y actividad de insiders de Adicet Bio, Inc. (ACET): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $9.05 |
| Capitalización | $85M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-05 | Klickstein Lloyd | A-Award | 18,300 | $168K |
| 2026-06-19 | Schor Chen | A-Award | 55,000 | $446K |
| 2026-06-19 | Aftab Blake | A-Award | 55,000 | $446K |
| 2026-06-21 | DUBIN STEVE | A-Award | 4,200 | $34K |
| 2026-06-21 | Chodakewitz Jeffrey | A-Award | 4,200 | $34K |
| 2026-06-21 | Grissinger Michael | A-Award | 4,200 | $34K |
| 2026-06-21 | Sinclair Andrew | A-Award | 4,200 | $34K |
| 2026-06-21 | Peng Katie | A-Award | 4,200 | $34K |
| 2026-06-21 | Klickstein Lloyd | A-Award | 4,200 | $34K |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | J-Other | 250,000 | $25 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $66.8M | $53.3M | $7.0M | $10.6M | $84.3M | $277.5M | $257.7M | $159.7M | $56.5M | $38.9M |
| Inversiones a Corto | $881000 | 0 | $101.0M | $51.8M | $10.3M | 0 | 0 | 0 | $119.8M | $119.6M |
| Cuentas por Cobrar | $167.6M | 0 | 0 | $935000 | $2.7M | $214000 | $435000 | 0 | 0 | $342000 |
| Inventario | $98.1M | $136.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $352.7M | $54.2M | $109.5M | $64.2M | $100.3M | $282.4M | $261.0M | $162.3M | $180.1M | $160.9M |
| Inmovilizado Material | $10.0M | $39000 | $321000 | $2.1M | $25.9M | $35.0M | $49.0M | $44.2M | $36.8M | $28.5M |
| Fondo de Comercio | $67.9M | $237.0M | 0 | 0 | $20.1M | $19.5M | $19.5M | 0 | 0 | 0 |
| Activos Intangibles | $79.1M | $285.1M | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $540.8M | $55.2M | $109.9M | $81.6M | $153.8M | $338.9M | $330.7M | $207.3M | $220.2M | $192.4M |
| Cuentas por Pagar | 0 | $1.5M | $538000 | $1.1M | $1.6M | $3.3M | $4.4M | $2.6M | $4.8M | $4.7M |
| Deuda a Corto | $197000 | $14.5M | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $98.9M | $5.5M | $5.7M | $14.9M | $22.5M | $16.3M | $19.7M | $19.3M | $19.4M | $21.5M |
| Deuda a Largo | $118.6M | $339.2M | $3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $236.3M | $5.5M | $5.7M | $142.0M | $44.0M | $35.8M | $38.4M | $37.1M | $33.6M | $33.1M |
| Reservas | $194.8M | -$33.8M | -$71.4M | -$69.6M | -$106.3M | -$168.3M | -$238.1M | -$380.8M | -$497.9M | -$614.7M |
| Patrimonio Neto | $304.4M | $49.7M | $104.2M | -$60.4M | $109.8M | $303.1M | $292.3M | $170.2M | $186.6M | $159.2M |
| Deuda Total | $118.8M | $353.7M | $3.1M | 0 | $21.6M | $20.9M | $21.0M | $20.9M | $17.2M | $14.7M |
| Deuda Neta | $51.1M | $300.3M | -$104.9M | -$62.4M | -$73.0M | -$256.6M | -$236.6M | -$138.8M | -$159.1M | -$143.8M |
| Capital Circulante | $253.8M | $48.7M | $103.8M | $49.3M | $77.9M | $266.1M | $241.3M | $143.0M | $160.7M | $139.4M |
Salud financiera
| Deuda / Patrimonio | 0.11 |
| Ratio corriente | 6.71 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.65 |
Rentabilidad
| Rentabilidad sobre capital | -74.90% |
| Rentabilidad sobre capital invertido | -77.98% |
| Rentabilidad sobre activos | -66.80% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACRV · ADAG · CRVO · GANX · HOWL · IMUX · IOBT
Explorar sector: Healthcare · Biotechnology
Más secciones de ACET: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones